The global biotechnology industry was worth $84.6 billion in 2010 and is projected to grow to $103 billion by 2013, with major markets in the United States, Europe, Australia, and Asia-Pacific. The Indian biotechnology industry was worth Rs. 17,249.34 crores in 2012 and is expected to grow at a rapid rate of 21.5% annually to reach $11.7 billion by 2017, driven by India's large population, increased healthcare spending, and growth in biopharmaceutical exports. However, both industries face challenges from regulatory pressures, innovation and funding demands, as well as intellectual property issues.

1. Fact Sheet – Biotechnology Industry
2012
 Global:
• The global biotech industry was $84.6 billion in 2010 and is expected to grow at a 7% CAGR to
$103 billion by 2013
Major Markets: USA, Europe, Australia, Asia-Pacific, Canada
Growth Drivers
• Active participation by private players
• Rising information technology innovation
• Improving healthcare infrastructure worldwide
Major issues
• Increasing regulatory demands, increasing funding and innovation pressures, environment
sustainability, food safety and security, human health & medicine
 India:
• The Indian biotech Industry was Rs.17249.34 crores and is expected to grow at 21.5 % CAGR.
India contributed 28.66% to overall USD 128.26 billion Asia – Pacific market. It is expected to
reach USD 11.7 Billion by 2017
Major Segments and Contribution
• Biopharma – 61.77%, Bioservices -18.82%, Bioagri – 14.38%, BioIndustrial – 3.63%,
Bioinformatics – 1.41%. Bioagri is promising field which is growing at rate of 28%
Growth Drivers
• India’s large population is huge market for Biotech products
• Increased healthcare expenditure due to rising income
• Strong growth in export demand
• Increasing number of Indian pharmaceutical players entering into biotech segment
Positives: India's human gene pools offering an exciting opportunity for genomics
Negatives: Radical cost-cutting in healthcare budgets coupled with escalating drug development
costs
Major Issues: Intellectual Property Rights is granted only for invention and not for discoveries, in
India
Sources:
• Bourne Capital Partners – June 2011, E&Y Beyond Borders –Global Biotechnology Report 2011, Biospectrumindia -The Ninth Survey
of Indian Biotech Industry June 2011, businesstoday.intoday.in, ENVIS Newsletter on Environmental Biotechnology of
Ministry Of Environment & Science, Govt.of India, www.fbae.org(Foundation for Biotechnology Awareness and Education)
• Interlink Knowledge Cell